Higher Prevalence of Coronary Artery Diseases to Propel Interventional Cardiology Devices Market to USD 9.6 Billion by 2020

The global interventional cardiology devices market is estimated to reach USD 9.6 Billion in 2020, growing at a CAGR of 8.8% from 2016 to 2020, according to a new market research report Interventional Cardiology Devices Market – Global Cardiac Stents, Catheters, Balloons and Imaging Systems Analysis and Forecast 2013-2020, published by iHealthcareAnalyst, Inc.

Visit the Interventional Cardiology Devices Market – Global Cardiac Stents, Catheters, Balloons and Imaging Systems Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/interventional-cardiology-devices-market/

Interventional cardiology involves various non-surgical procedures for treating cardiovascular disease by using drug-eluting stents, bare-metal stents, percutaneous transluminal coronary angioplasty (PTCA) and cutting balloon catheters. The global interventional cardiology devices market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on the type of device used (stents – bare metal, bio-absorbable, drug eluting; catheters – angiography, guiding, IVUS, pulmonary arterial catheters; PTCA balloons – normal, drug eluting, cutting, scoring; imaging systems such as FFR, IVUS, OCT; PTCA guidewires, etc.), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and/or services offered, and recent trends in strategic management.

The global interventional cardiology devices market is segmented as:

1. Device Type
1.1. Stents
1.1.1. Bare Metal Stents
1.1.2. Bio-absorbable Stents
1.1.3. Drug-Eluting Stents
1.2. Catheters
1.2.1. Angiography Catheters
1.2.2. Guiding Catheters
1.2.3. Intravascular ultrasound (IVUS) Catheters
1.2.4. Pulmonary Artery Catheters
1.3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
1.3.1. Cutting Balloons
1.3.2. Drug-eluting Balloons
1.3.3. Normal Balloons
1.3.4. Scoring Balloons
1.4. Imaging Systems
1.4.1. Fractional Flow Reserve (FFR)
1.4.2. Intravascular Ultrasound (IVUS)
1.4.3. Optical Coherence Tomography (OCT)
1.5. PTCA Guidewires
1.6. Others

2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
4. Abbott Laboratories, Inc.
5. B. Braun Melsungen AG
6. Boston Scientific Corporation
7. Cook Medical, Inc.
8. Johnson & Johnson (Cordis Corporation)
9. Medtronic, Inc.
10. Smiths Medical
11. St. Jude Medical, Inc.
12. Terumo Corporation

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.